#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	14076	16S	1529	1529	100.0	16S.l15.c4.ctg.1	2049	674.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1411	1411	C	793	C	750	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26438	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3496	744.5	0	.	n	.	0	T695C	SNP	695	695	T	1064	1064	C	813	C	779	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26438	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3496	744.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1706	1706	A	856	A,G	822,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26438	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3496	744.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2340	2340	C	847	C	805	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26438	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3496	744.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2414	2414	A	827	A	795	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26438	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3496	744.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2966	2966	C	757	C	721	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	1726	folP	852	852	100.0	folP.l6.c4.ctg.1	1445	117.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1030	1032	AGC	179;178;178	A;G;C	174;173;171	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4492	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3555	124.9	1	SNP	p	S91F	1	.	.	271	273	TTC	620	622	TTC	156;158;158	T;T;C	143;147;146	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4492	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3555	124.9	1	SNP	p	G95N	0	.	.	283	285	GGC	632	634	GGC	160;158;153	G;G;C	152;149;145	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4492	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3555	124.9	1	SNP	p	D95G	1	.	.	283	285	GGC	632	634	GGC	160;158;153	G;G;C	152;149;145	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1358	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1369	97.7	0	.	p	.	0	A39T	NONSYN	115	117	GCC	383	385	ACC	154;153;154	A,G;C;C	143,1;149;150	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1358	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1369	97.7	0	.	p	.	0	R44H	NONSYN	130	132	CGC	398	400	CAC	156;156;157	C;A;C	154;149;153	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1358	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1369	97.7	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	581	583	CAC	155;157;157	C,T;A,C;C	146,1;149,1;151	.	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	539	1358	mtrR	633	633	99.21	mtrR.l15.c17.ctg.1	1369	97.7	1	SNP	p	G45D	0	.	.	133	135	GGC	401	403	GGC	157;157;158	G;G;C,A	154;153;154,1	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	794	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1055	74.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4400	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2915	149.1	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1396	1398	GTC	153;151;150	G;T;C,A	151;144;144,2	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4400	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2915	149.1	1	SNP	p	D86N	0	.	.	256	258	GAC	502	504	GAC	171;171;172	G;A,G;C	163;157,1;164	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4400	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2915	149.1	1	SNP	p	R87W	0	.	.	259	261	CGT	505	507	CGT	171;173;175	C,A;G;T	164,1;164;161	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4400	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2915	149.1	1	SNP	p	S87R	1	.	.	259	261	CGT	505	507	CGT	171;173;175	C,A;G;T	164,1;164;161	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4400	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2915	149.1	1	SNP	p	R87I	0	.	.	259	261	CGT	505	507	CGT	171;173;175	C,A;G;T	164,1;164;161	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4400	parC	2304	2304	99.87	parC.l6.c4.ctg.1	2915	149.1	1	SNP	p	S88P	0	.	.	262	264	TCC	508	510	TCC	175;176;178	T;C;C	163;169;170	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3646	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2606	137.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1534	1536	GGC	174;173;171	G;G;C	169;164;157	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1137	1139	GCA	174;174;178	G;C;A	161;161;167	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1140	1142	ATC	178;178;181	A;T;C	167;163;170	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1152	1154	GTG	185;184;185	G;T,G,A;G	173;169,1,1;173	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1152	1154	GTG	185;184;185	G;T,G,A;G	173;169,1,1;173	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1656	1658	ACC	145;146;148	A;C;C	135;134;140	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1710	1712	GCG	136;135;135	G;C,G;G	125;121,1;125	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1710	1712	GCG	136;135;135	G;C,G;G	125;121,1;125	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1833	1835	GGC	141;139;137	G;G,A;C	133;129,1;129	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1842	1844	GGC	129;126;126	G;G;C	124;120;119	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	3442	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2199	153.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	1860	1862	CCG	97;96;96	C,CGG;C,G;G,C	79,1;84,2;79,1	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	527	4986	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3136	156.5	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1706	1708	CTG	170;168;170	C;T;G,A	156;150;156,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	527	4986	ponA	2397	129	98.45	ponA.l15.c4.ctg.2	129	0.8	0	.	p	.	0	T346P	NONSYN	1036	1038	ACC	64	66	CCC	1;1;1	C;C;C	1;1;1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2100	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1693	122.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	530	530	C	144	C	138	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	V75I	NONSYN	223	225	GTT	548	550	ATT	190;189;189	A;T;T	178;180;182	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	T87A	NONSYN	259	261	ACT	584	586	GCT	174;175;174	G,A;C;T	168,1;170;166	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	T89S	NONSYN	265	267	ACC	590	592	AGC	175;173;173	A;G;C	170;167;165	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	V98I	NONSYN	292	294	GTC	617	619	ATC	177;178;181	A;T;C,T	172;169;175,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	.	MULTIPLE	358	359	AA	682	683	CG	172;171	C;G	167;160	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	.	MULTIPLE	361	362	GA	685	687	CAG	172;175;174	C;A;G	164;164;168	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	N122K	NONSYN	364	366	AAC	689	691	AAA	173;174;181	A;A;A	166;170;177	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	716	718	TAT	193;193;192	T;A;T	183;185;182	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	N134E	NONSYN	400	402	AAT	725	727	GAG	185;187;188	G;A;G	175;180;180	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	V135F	NONSYN	403	405	GTG	728	730	TTT	186;183;182	T;T;T	173;174;176	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	G140K	NONSYN	418	420	GGA	743	745	AAA	175;175;177	A;A;A	171;171;172	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	K143E	NONSYN	427	429	AAA	752	754	GAA	175;174;175	G;A;A	167;163;168	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	776	778	GCA	196;197;197	G;C;A,C	188;193;191,1	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	I209M	NONSYN	625	627	ATC	950	952	ATG	208;207;208	A;T;G	196;194;191	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	959	959	T	199	T	185	.	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	1	SNP	p	G120K	1	.	.	358	360	AAG	682	684	CGG	172;171;173	C;G;G	167;160;167	porB1b.WHO_O_01976:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	1	SNP	p	A121D	1	.	.	361	363	GAC	685	688	CGC	172;174;172	C;G;C	164;168;164	porB1b.WHO_O_01976:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_O_01976	porB1b.WHO_O_01976	1	1	539	2428	porB1b	1041	1041	95.71	porB1b.l15.c30.ctg.1	1505	158.7	1	SNP	p	D121N	0	.	.	361	363	GAC	685	688	CGC	172;174;172	C;G;C	164;168;164	porB1b.WHO_O_01976:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	8898	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4732	186.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	1908	1910	AAT	196;197;196	A;A;T,A	190;191;189,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1044	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	985	103.2	1	SNP	p	V57M	1	.	.	169	171	ATG	503	505	ATG	195;197;198	A;T;G	186;188;189	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
